Showing results (141-150 of 463) with videos related to
Sort By:
Pageof 47
Frontiers in Neurology|June 30, 2020
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-ViewpointCarolina Sportelli, Daniele Urso, Peter Jenner, et al.Brain Research|August 4, 2010
The effects of dose and route of administration of PSI on behavioural and biochemical indices of neuronal degeneration in the rat brainSalma Bukhatwa, Bai-Yun Zeng, Sarah Rose, et al.Brain Research|November 10, 2004
Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degenerationMahmoud M Iravani, Lin Liu, Sarah Rose, et al.Journal of Neuroscience Research|September 1, 2005
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insultsDong-Hoon Hyun, Moonhee Lee, Barry Halliwell, et al.Parkinsonism & Related Disorders|November 11, 2021
Dose optimization of apomorphine sublingual film for treating "OFF" episodes in Parkinson's diseaseC Warren Olanow, Fabrizio Stocchi, Elizabeth L Peckham, et al.Nature Reviews. Neuroscience|June 9, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter JennerParkinsonism & Related Disorders|October 14, 2015
Non motor subtypes and Parkinson's diseaseAnna Sauerbier, Peter Jenner, Antoniya Todorova, et al.Nature Reviews. Neuroscience|July 20, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter JennerJournal of Neural Transmission (Vienna, Austria : 1996)|May 1, 2014
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell lossMahmoud M Iravani, Mona Sadeghian, Sarah Rose, et al.Clinical Therapeutics|January 30, 2010
Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studiesPeter Jenner, Michael Könen-Bergmann, Cornelia Schepers, et al.Pageof 47